Bluebird Bio Inc (BLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 353,468 | 439,714 | 260,629 | 324,164 | 1,198,768 |
| Marketable Securities | 486,233 | 572,722 | 419,599 | 906,091 | 350,614 |
| Receivables | 16,597 | N/A | 3,872 | N/A | N/A |
| Inventories | 13,502 | 18,079 | 10,698 | N/A | N/A |
| Other current assets | 0 | 24,762 | 495,021 | 27,517 | 24,705 |
| TOTAL | $903,526 | $1,097,535 | $1,215,537 | $1,293,194 | $1,613,445 |
| Non-Current Assets | |||||
| PPE Net | 158,820 | 165,198 | 17,373 | 157,681 | 155,376 |
| Investments And Advances | 101,927 | 81,115 | 61,445 | 207,615 | 49,411 |
| Intangibles | 29,391 | 24,597 | 10,043 | 24,240 | 25,311 |
| Other Non-Current Assets | 260,795 | 268,834 | 476,854 | 262,754 | 264,247 |
| TOTAL | $550,933 | $539,744 | $565,715 | $652,290 | $494,345 |
| Total Assets | $1,454,459 | $1,637,279 | $1,781,252 | $1,945,484 | $2,107,790 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 39,294 | 20,232 | 13,811 | 25,309 | 26,181 |
| Accrued Expenses | 168,035 | 146,791 | 98,190 | 138,274 | 135,612 |
| Other current liabilities | 9,080 | 9,899 | N/A | 10,045 | 10,518 |
| TOTAL | $247,765 | $206,315 | $203,588 | $196,907 | $197,181 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,687 | 1,330 | N/A | 1,061 | 3,915 |
| Other Non-Current Liabilities | 196,371 | 204,869 | 222,608 | 199,794 | 202,816 |
| TOTAL | $222,133 | $230,631 | $222,608 | $225,556 | $228,578 |
| Total Liabilities | $469,898 | $436,946 | $426,196 | $422,463 | $425,759 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,379 | 3,372 | 3,357 | 3,319 | 3,311 |
| Common Shares | 676 | 675 | 665 | 663 | 662 |
| Retained earnings | -3,348,057 | -3,106,355 | -2,900,547 | -2,700,673 | -2,505,928 |
| Other shareholders' equity | -5,777 | -5,449 | -5,505 | -4,223 | -2,400 |
| TOTAL | $984,561 | $1,200,333 | $1,355,056 | $1,523,021 | $1,682,031 |
| Total Liabilities And Equity | $1,454,459 | $1,637,279 | $1,781,252 | $1,945,484 | $2,107,790 |